Sponsor

Fondazione Arianna Anticoagulazione

Italy Via Paolo Fabbri 1/3, 40138 Bologna, Italy

About the sponsor

The sponsor’s clinical research is centered on preventing recurrence after a first episode of venous thromboembolism, with attention to patients who have experienced deep vein thrombosis or pulmonary embolism.

Secondary prevention after first VTE
Deep vein thrombosis
Pulmonary embolism

The therapeutic interest is focused on reducing the risk of relapse in this cardiovascular and thromboembolic setting.

About Specializations

Fondazione Arianna Anticoagulazione runs clinical trials in conditions such as Pulmonary embolism, Venous thrombosis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Pulmonary embolism+1

Not yet recruiting

Registered drug

Study on Sulodexide for Preventing Recurrence of Blood Clots in Elderly Patients After First Episode of Deep Vein Thrombosis or Pulmonary Embolism

Registered drug

Italy

Participants:65+ years
Substances:Sulodexide
Sponsor:Fondazione Arianna Anticoagulazione

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →